Epigenetic analysis of 6-base genome in Parkinson’s
31 Jul 2025
The emergence of the ‘6-base genome’, which includes the modified bases 5-methylcytosine (5mC) and its oxidised form, 5-hydroxymethylcytosine (5hmC), marks a significant evolution in our understanding of genetic and epigenetic regulation.
In this webinar, Burleen Chhatwal from University College London, UK, demonstrates how biomodal’s 6-base genome supported the successful analysis of both 5mC and 5hmC modifications in Parkinson’s disease compared to controls in a pilot study.
Related Products
Request Quote for All Products
duet multiomics solution evoC
biomodalYour single solution for multiomics data - Uncover a true 6-base genome for unprecedented insights into current and future biological states. Access all four canonical bases and distinguish 5‑methylcytosine (5mC) and 5‑hydroxymethylcytosine (5hmC) from a single 5ng DNA sample, in a single experiment, with high accuracy.
